47th Annual Securities Regulation Institute

47th Annual Securities Regulation Institute

Hotel del Coronado
Speaking Engagement

One of the most visible and highly-regarded securities and corporate law conferences in the country, the Securities Regulation Institute reaches prominent attorneys from both firm and in-house practices. From boardroom updates to issues impacting pre-public companies, the institute focuses on practical advice for all attorneys advising corporate clients in the ever-changing world of securities and business law. During this three-day event, attendees learn from regulators who write the new regulations, judges who interpret the law to resolve complex disputes, and prominent practitioners who guide their clients through the maze of new legislation, regulations and jurisprudence.

On Monday, January 27, WilmerHale Partner and Securities Regulation Institute Chair Meredith Cross will provide welcome remarks and an overview of the conference. She will also serve as a panelist during the session “Crisis Management,” which will focus on managing the board process during a crisis; roles of internal and external counsel; navigating the inevitable investor relations and media communications challenges; best practices for addressing challenges faced by boards and their advisers; and structuring and carrying out internal investigations.

On Tuesday, January 28, WilmerHale Partner Lilian Brown will serve as session chair during “Proxy Developments,” focusing on new disclosures and trends for proxy statement developments, shareholder proposals and engagement, and the role and regulation of proxy advisers.

Read More About the Event

Speakers

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.